Her research goals are to identify and validate molecular markers of cancer risk, progression, and outcomes, and the regulation of cancer growth via these pathways and the implications for racial/ethnic disparities. Efforts in her laboratory provided understanding on the impact of the RNA stabilization pathway on tumor progression, and elucidated the tumor suppressor role of tristetraprolin in brain cancer.